RDIV vs. PPH
RDIV (Invesco S&P Ultra Dividend Revenue ETF) and PPH (VanEck Pharmaceutical ETF) are both exchange-traded funds - RDIV is a Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index, while PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 10 years, RDIV returned 11.04%/yr vs 8.39%/yr for PPH. A 0.50 correlation means they provide meaningful diversification when combined. RDIV charges 0.39%/yr vs 0.36%/yr for PPH.
Performance
RDIV vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RDIV achieves a 14.73% return, which is significantly higher than PPH's 2.96% return. Over the past 10 years, RDIV has outperformed PPH with an annualized return of 11.04%, while PPH has yielded a comparatively lower 8.39% annualized return.
RDIV
- 1D
- -1.73%
- 1M
- 5.67%
- YTD
- 14.73%
- 6M
- 12.64%
- 1Y
- 29.81%
- 3Y*
- 18.46%
- 5Y*
- 10.99%
- 10Y*
- 11.04%
PPH
- 1D
- -1.04%
- 1M
- 4.48%
- YTD
- 2.96%
- 6M
- 3.80%
- 1Y
- 18.69%
- 3Y*
- 12.38%
- 5Y*
- 9.47%
- 10Y*
- 8.39%
RDIV vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RDIV Invesco S&P Ultra Dividend Revenue ETF | 14.73% | 12.36% | 15.17% | 4.66% | 7.16% | 29.12% | -9.31% | 22.62% | -4.78% | 11.63% |
PPH VanEck Pharmaceutical ETF | 2.96% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between RDIV and PPH is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2013 | 0.50 |
The correlation between RDIV and PPH shifts across timeframes, from 0.34 (1 year) to 0.51 (10 years), reflecting how their relationship changes across market environments.
RDIV vs. PPH - Sectors Allocation Comparison
Sectors
RDIV
PPH
Financial Services
-
Energy
-
Consumer Cyclical
-
Consumer Defensive
-
Communication Services
-
Real Estate
-
Healthcare
Technology
-
Utilities
-
Basic Materials
-
Industrials
-
Financial Services
RDIV
PPH
-
Energy
RDIV
PPH
-
Consumer Cyclical
RDIV
PPH
-
Consumer Defensive
RDIV
PPH
-
Communication Services
RDIV
PPH
-
Real Estate
RDIV
PPH
-
Healthcare
RDIV
PPH
Technology
RDIV
PPH
-
Utilities
RDIV
PPH
-
Basic Materials
RDIV
PPH
-
Industrials
RDIV
-
PPH
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RDIV vs. PPH — Risk / Return Rank
RDIV
PPH
RDIV vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P Ultra Dividend Revenue ETF (RDIV) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RDIV | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.20 | ||
| Sortino ratioReturn per unit of downside risk | +1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.20 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 6.18 | 1.74 | +4.44 |
| Martin ratioReturn relative to average drawdown | 18.36 | 4.30 | +14.06 |
Loading charts...
Drawdowns
RDIV vs. PPH - Drawdown Comparison
The maximum RDIV drawdown since its inception was -49.97%, roughly equal to the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for RDIV and PPH.
Loading charts...
Drawdown Indicators
| RDIV | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.97% | -51.45% | +1.48% |
Max Drawdown (1Y)Largest decline over 1 year | -4.84% | -10.76% | +5.92% |
Max Drawdown (3Y)Largest decline over 3 years | -17.91% | -18.06% | +0.15% |
Max Drawdown (5Y)Largest decline over 5 years | -24.89% | -20.26% | -4.63% |
Max Drawdown (10Y)Largest decline over 10 years | -49.97% | -29.70% | -20.27% |
Current DrawdownCurrent decline from peak | -1.73% | -4.90% | +3.17% |
Average DrawdownAverage peak-to-trough decline | -5.85% | -17.29% | +11.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.63% | 4.45% | -2.82% |
Volatility
RDIV vs. PPH - Volatility Comparison
The current volatility for Invesco S&P Ultra Dividend Revenue ETF (RDIV) is 4.07%, while VanEck Pharmaceutical ETF (PPH) has a volatility of 5.95%. This indicates that RDIV experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RDIV | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.07% | 5.95% | -1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 8.83% | 12.18% | -3.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.26% | 17.66% | -4.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.56% | 15.14% | +2.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.90% | 17.00% | +4.90% |
RDIV vs. PPH - Expense Ratio Comparison
RDIV has a 0.39% expense ratio, which is higher than PPH's 0.36% expense ratio.
Dividends
RDIV vs. PPH - Dividend Comparison
RDIV's dividend yield for the trailing twelve months is around 3.57%, more than PPH's 2.05% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.05% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 3.57% | 3.94% | 4.08% | 3.93% | 3.44% | 3.31% | 4.93% | 3.84% | 4.32% | 4.26% | 2.20% | 4.49% |
Frequently Asked Questions
RDIV and PPH have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (5.95%) compared to RDIV (4.07%). In terms of maximum drawdown, RDIV dropped -49.97% vs PPH's -51.45%.
On 10-year performance, RDIV leads with 11.04% vs 8.39% for PPH. On fees, PPH is cheaper at 0.36% per year. On volatility, RDIV has been the lower-risk option at 4.07%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, RDIV has performed better with a 11.04% return vs 8.39%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.39% for RDIV.
RDIV has the higher dividend yield at 3.57%, compared with 2.05% for PPH.
RDIV is categorized as Mid Cap Value Equities, while PPH is Health & Biotech Equities. RDIV tracks S&P 900 Dividend Revenue-Weighted Index, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Invesco and VanEck. Their fees differ too: 0.39% for RDIV and 0.36% for PPH.
RDIV currently has the higher Sharpe Ratio (2.26 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RDIV and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer